Osiris Therapeutics, Inc. , the leading company focused on developing and marketing stem cell products to treat serious medical conditions, announced today the introduction of a proprietary, direct sales force for GrafixA , a premium cellular repair matrix for serious wounds including diabetic foot ulcers.
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130301005401&newsLang=en&ndmConfigId=1000639&vnsId=41
http://www.businesswire.com/portal/site/topix/index.jsp?ndmViewId=news_view&newsId=20130301005401&newsLang=en&ndmConfigId=1000639&vnsId=41
No comments:
Post a Comment